Cas:35795-16-5 (2-hydroxy-2-methylpropyl) 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate manufacturer & supplier

We serve Chemical Name:(2-hydroxy-2-methylpropyl) 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate CAS:35795-16-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2-hydroxy-2-methylpropyl) 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate

Chemical Name:(2-hydroxy-2-methylpropyl) 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate
CAS.NO:35795-16-5
Synonyms:trimazosine;TRIMAZOSIN;EINECS 252-732-7
Molecular Formula:C20H29N5O6
Molecular Weight:435.47400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:648.2ºC at 760mmHg
Density:1.31g/cm3
Index of Refraction:1.606
PSA:132.50000
Exact Mass:435.21200
LogP:1.85140

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like trimazosine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 252-732-7 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,trimazosine Use and application,TRIMAZOSIN technical grade,usp/ep/jp grade.


Related News: By integrating biocatalysis into ongoing and newly launched projects, Wavelength Pharmaceuticals has shown that it is possible to reduce overall costs by as much as 30%. 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid,2,3-dihydro-9-(4-morpholinylmethyl)-7-oxo-2-phenyl-, ethyl ester manufacturers Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. 4-(((N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N-tosyl-L-arginyl)oxy)methyl)-3-nitrobenzoic acid suppliers The PLI scheme aims to accelerate indigenous manufacturing of critical bulk drugs for which India is dependent on imports. Under this scheme government offered incentives varying between 10 to 20%. 3α-Hydroxymethyl-3-methyl-1-p-tolylnorbornan-2α-ol vendor & factory.